TCT 706: One-Year Pooled Outcomes of Transcatheter Arterialization of the Deep Veins From the PROMISE I, II, and UK Studies

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker's Bureau - Medtronic; Abbott; Terumo Medical Corporation; Boston Scientific Corporation; Phillips
• Equity/Stock(s)/Options - ANT; Inquis